The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
The drug, suzetrigine, received the FDA's official stamp of approval Thursday to be sold ... it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...